Haemodialysis-induced changes in pulmonary functions

O. Karacan, E. Tutal, S. Akçay, M. Uyar, F. O. Eyuboglu (Ankara, Turkey)

Source: Annual Congress 2003 - Pulmonary disease in systemic disorders
Session: Pulmonary disease in systemic disorders
Session type: Thematic Poster Session
Number: 424
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Karacan, E. Tutal, S. Akçay, M. Uyar, F. O. Eyuboglu (Ankara, Turkey). Haemodialysis-induced changes in pulmonary functions. Eur Respir J 2003; 22: Suppl. 45, 424

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Mechanisms underlying pulmonary vascular changes in COPD patients
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019


The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
Source: Eur Respir Rev 2014; 23: 350-355
Year: 2014



Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008


Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009


Pulmonary vascular and cardiac impairment in interstitial lung disease
Source: Eur Respir Rev 2017; 26: 160128
Year: 2017



Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018


Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Pulmonary vascular response patterns during exercise in interstitial lung disease
Source: Eur Respir J 2015; 46: 738-749
Year: 2015



Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Characterization of peripheral airway obstruction by pulmonary function parameters
Source: Virtual Congress 2020 – Lung function diagnostics
Year: 2020


Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001

The importance of cardiac function in pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Pulmonary hypertension in idiopathic pulmonary fibrosis: correlation to pulmonary function and exercise parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007

The effects of pulmonary circulation on the volume-dependent behaviour of the lungs
Source: Eur Respir J 2002; 20: Suppl. 38, 11s
Year: 2002

Changes of the recruitment characteristics of the pulmonary vascular bed in pulmonary hypertension measured by intra breath diffusion
Source: Eur Respir J 2003; 22: Suppl. 45, 146s
Year: 2003

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018



Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007